Research

Spirulina extract’s effects on seniors’ health

October 10, 2013 — by Jack Mazurak
AlgaeIndustryMagazine.com

Dr. Gailen Marshall displays immulina in its capsule form.

Dr. Gailen Marshall displays immulina in its capsule form.

Can spirulina, the blue-green algae rich in linoleic acids, B vitamins and a variety of minerals – and used for centuries across ancient cultures to promote better health – improve immune systems in today’s seniors?

A clinical trial still enrolling participants is under way, at the University of Mississippi Medical Center (UMMC) in the Division of Allergy and Immunology, to test the theory that it may.

The pilot study at UMMC aims to identify whether and how much of the spirulina extract immulina it takes to improve the immune response of adults 60 and older. Seniors stand a greater risk for complications from colds, flu and other common infections.

“As people age, their susceptibility to mortality from influenza increases,” said Dr. Gailen Marshall, professor and R. Faser Triplet Sr. M.D. Chair in Allergy and Immunology. “Even the flu vaccine becomes less effective for them.”

Immulina magnified

Immulina magnified

Similarly, people’s immune systems weaken with age. That’s why older people die from infections, including flu, pneumonia, West Nile virus and sepsis, more often than younger people.

“If we can improve people’s immune system response with immulina, they may respond more robustly to the vaccine, which would better prepare their bodies to fight off the actual, live flu virus,” Marshall said.

He plans to enroll 50 people into the study. He began taking volunteers in August and will accept more on a rolling basis.

Participants will receive an envelope of pills – either immulina or a placebo – to take four times daily. They will visit a UMMC clinic weekly for four weeks to fill out questionnaires and give saliva samples and two tablespoons of blood.

After researchers collect the remaining pills, participants will make two return visits two weeks apart. By analyzing blood and saliva samples taken during and after the immulina treatment, Marshall and his team will be able to tell to what level and how long the immune-boosting effects lasted.

For the pilot study, Marshall is working with the National Center for Natural Products Research at the University of Mississippi, which is supplying and preparing the immulina. “I’ve collaborated for a couple years with Dr. Larry Walker and Dr. David Pascoe,” Marshall said. “They’d been working with immulina for a while and have considered it for use in cancer patients.”

If the results show promise, Marshall will apply to the National Institutes of Health to fund an investigation of immulina’s abilities to boost the effectiveness of flu vaccines in seniors. “That study would also consider whether immulina’s effects are different based on gender and race,” he said.

The pilot represents a piece in a larger puzzle, too. Marshall aims to establish a center for integrative medicine at UMMC that will investigate, teach and practice proven treatments and methods from the world’s major medical systems.

More Like This…

HOME A.I.M. Archives

Copyright ©2010-2015 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Algatech has announced the opening of Algatech Inc., a New York City-based subsidiary created to serve the North American market. The company has appointed Ken Seguine to...
Adoption of advanced technologies in various stages of natural astaxanthin production, such as microalgae harvesting, cultivation, extraction, and drying, have been major...
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating arthritis. This is based on a polysaccharide, a long-c...
The European Synchrotron Radiation Facility (ESRF) reports that an international team has discovered an enzyme which allows microalgae to convert some of their fatty acid...
Portuguese microalgae producer, Allmicroalgae Natural Products S.A., has recently begun production of Chlorella vulgaris and other microalgae species via fermentation, wh...
Ali Morris writes in dezeen.com that Dutch designers Eric Klarenbeek and Maartje Dros have developed a bioplastic made from algae, which they believe could completely rep...
Trade Arabia reports that the Oman Centre for Marine Biotechnology (OCMB) recently signed a memorandum of understanding with Swedish Algae Factory to support the domestic...
The recently signed US two-year budget deal – featuring bipartisan support for a $35 per ton tax incentive for carbon captured and recycled from power plants or industria...
The Natural Algae Astaxanthin Association (NAXA), headquartered in Spring, Texas, has announced that Chile-based Atacama Bio is its newest executive member. Atacama Bio h...
Israeli-based Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health New Zealand, Ltd. (Supreme) to supply the rapidly growing markets in Ch...
At the Technical University of Denmark (DTU), Science Nordic.com reports, researchers are investigating bioluminescent algae, to determine whether bioluminescent organism...
Israeli-based Algatechnologies, Ltd. (Algatech), is teaming up with the Italian R&D company, Sphera Encapsulation S.r.l (Sphera), to develop innovative functional ingredi...